Diagnosis and management of hereditary haemochromatosis.

Murphree, Catherine R; Nguyen, Nga N; Raghunathan, Vikram; Olson, Sven R; DeLoughery, Thomas; Shatzel, Joseph J

Murphree, Catherine R; Nguyen, Nga N; Raghunathan, Vikram; Olson, Sven R; DeLoughery, Thomas; Shatzel, Joseph J.

Afiliação

Murphree CR; Division of Hematology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Nguyen NN; Division of Hematology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Raghunathan V; Division of Hematology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Olson SR; Division of Hematology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
DeLoughery T; Division of Hematology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Shatzel JJ; Division of Hematology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.

Vox Sang ; 115(4): 255-262, 2020 May.

Article em En | MEDLINE | ID: mdl-32080859

Assuntos

Hemocromatose/diagnóstico; Hemocromatose/terapia; Humanos; Programas de Rastreamento; Flebotomia/métodos

Palavras-chave

blood components; transfusion medicine; transfusion strategy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemocromatose Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Vox Sang Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google